Polymyxin B-hemoperfusion in patients with acute exacerbation of idiopathic pulmonary fibrosis: a single-center prospective pilot study
Min Jee Kim, Jiyoul Yang, Jin Woo Song
Korean J Intern Med. 2025;40(3):458-467. Published online 2025 Apr 30 DOI: https://doi.org/10.3904/kjim.2024.244
Citations to this article as recorded by 
Should nintedanib be continued after acute exacerbation of idiopathic pulmonary fibrosis? A retrospective observational study using a nationwide database in Japan
Hisayuki Shuto, Akihiko Hagiwara, Ryohei Kudoh, Hiroyuki Matsumoto, Shota Omori, Kiyohide Fushimi, Kosaku Komiya
Respiratory Medicine and Research.2026; 90: 101293. CrossRef
Polymyxin B-hemoperfusion in acute exacerbation of idiopathic pulmonary fibrosis: a feasibility step forward
Won-Il Choi
The Korean Journal of Internal Medicine.2025; 40(3): 345. CrossRef